193 related articles for article (PubMed ID: 24119169)
1. The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy.
Thanigaimani K; Mohamed F; Cecil T; Moran BJ; Bell J
Colorectal Dis; 2013 Dec; 15(12):1537-42. PubMed ID: 24119169
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei.
Ashraf-Kashani N; Bell J
Int J Hyperthermia; 2017 Sep; 33(6):675-678. PubMed ID: 28540781
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy.
Rankovic VI; Masirevic VP; Pavlov MJ; Ceranic MS; Milenkovic MG; Simic AP; Kecmanovic DM
Hepatogastroenterology; 2007 Mar; 54(74):364-6. PubMed ID: 17523275
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk?
Tsilimparis N; Bockelmann C; Raue W; Menenakos C; Perez S; Rau B; Hartmann J
Ann Surg Oncol; 2013 Jan; 20(1):226-32. PubMed ID: 22868919
[TBL] [Abstract][Full Text] [Related]
5. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
6. The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Kusamura S; Baratti D; Hutanu I; Gavazzi C; Morelli D; Iusco DR; Grassi A; Bonomi S; Virzì S; Haeusler E; Deraco M
Eur J Surg Oncol; 2015 Aug; 41(8):1097-105. PubMed ID: 26026742
[TBL] [Abstract][Full Text] [Related]
7. [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
Kavanagh M; Ouellet JF;
Bull Cancer; 2006 Sep; 93(9):867-74. PubMed ID: 16980229
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience.
Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2013 Dec; 68(6):569-77. PubMed ID: 24193289
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
[TBL] [Abstract][Full Text] [Related]
11. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.
Cole KL; Choudry HA; Jones HL; Goodell PP; Bartlett DL
J Surg Oncol; 2012 Sep; 106(4):513-6. PubMed ID: 22396067
[TBL] [Abstract][Full Text] [Related]
12. Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed.
Kuijpers AM; Hauptmann M; Aalbers AG; Nienhuijs SW; de Hingh IH; Wiezer MJ; van Ramshorst B; van Ginkel RJ; Havenga K; Verwaal VJ
Eur J Surg Oncol; 2016 Feb; 42(2):244-50. PubMed ID: 26375923
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
Deraco M; Kusamura S; Laterza B; Favaro M; Fumagalli L; Costanzo P; Baratti D
In Vivo; 2006; 20(6A):773-6. PubMed ID: 17203766
[TBL] [Abstract][Full Text] [Related]
14. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
15. Intra-abdominal pressure, Cardiac Index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study.
Schluermann CN; Hoeppner J; Benk C; Schmidt R; Loop T; Kalbhenn J
Minerva Anestesiol; 2016 Feb; 82(2):160-9. PubMed ID: 25971283
[TBL] [Abstract][Full Text] [Related]
16. Anesthetic management and renal function in pediatric patients undergoing cytoreductive surgery with continuous hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin.
Owusu-Agyemang P; Arunkumar R; Green H; Hurst D; Landoski K; Hayes-Jordan A
Ann Surg Oncol; 2012 Aug; 19(8):2652-6. PubMed ID: 22451231
[TBL] [Abstract][Full Text] [Related]
17. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg Oncol; 2007 Feb; 14(2):493-9. PubMed ID: 17103067
[TBL] [Abstract][Full Text] [Related]
18. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
19. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Iversen LH; Rasmussen PC; Laurberg S
Br J Surg; 2013 Jan; 100(2):285-92. PubMed ID: 23124619
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
Bouhadjari N; Gabato W; Calabrese D; Msika S; Keita H
Eur J Surg Oncol; 2016 Feb; 42(2):219-23. PubMed ID: 26278017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]